WinstonWongTanMDFACP

Oncology • Jacksonville, FL

Genitourinary Oncology, Hematologic Oncology, Melanoma

Chair of Genitourinary Medical Oncology Past Program Director Hematology Oncology Fellowship

Join to view full profile

Dr. Tan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tan's full profile

Already have an account?

Office
4500 San Pablo Road S
Jacksonville, FL 32224

Summary

Dr. Winston Tan is an oncologist in Jacksonville, FL and is affiliated with Mayo Clinic Hospital in Florida. He received his medical degree from University of Santo Tomas and has been in practice 31 years. He specializes in genitourinary oncology, hematologic oncology, and melanoma and is experienced in amyloidosis, hematologic oncology, testicular neoplasms, prostate cancer, and prostatitis.

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
Maimonides Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Santo TomasClass of 1986

Certifications & Licensure

FL State Medical License 2000 - 2026
TX State Medical License 1994 - 2026
MI State Medical License 1994 - 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

FASCO American Society of Clinical Oncology, 2023

Clinical Trials

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer Start of enrollment: 2004 Apr 01
Completed
Phase 2
Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2004 Aug 01
Completed
Phase 2
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2007 Aug 01
Completed
Phase 2
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Start of enrollment: 2007 Sep 01
Completed
Phase 3
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2010 Sep 01
Completed
Phase 1, Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy Start of enrollment: 2013 May 28
Active, not recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer Start of enrollment: 2022 Apr 04
Recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

473 citations
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, Meijun Du, Shu Xia
European Urology. 2015-01-01
275 citations
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline ...
Ronald C. Chen, R. Bryan Rumble, D. Andrew Loblaw, Antonio Finelli, Behfar Ehdaie
Journal of Clinical Oncology. 2016-09-27
26 citations
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)
Eva Gupta, Troy H. Guthrie, Winston Tan
BMC Urology. 2014-07-25

Abstracts/Posters

Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers
Winston Tan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Cancer Survivors Find Support, Strength, HopeJune 3rd, 2018
Mayo Clinic to Host Public Cancer Education Symposium in OrlandoFebruary 22nd, 2017

Committees

President, Florida Society of Clinical Oncology 2021 - 2023